Scientific program

International Symposium on Theranostics and Metabolic Diseases

Preliminary programme

Belgrade

Thursday, November 7, 2024

09:30-17:00

Registration

1

 Imaging cardiac amyloidosis
Chairpersons: Marija Zdravkovic, Jelena Bila
9:00-9:15 Jelena Bila, Belgrade AL Amyloidosis: Diagnostic and therapeutic algorithms
9:15-9:30 Marija Zdravkovic, Belgrade Magnetic resonance imaging in heart amyloidosis
9:30-9:45 Isidora Grozdic Milojevic, Belgrade Nuclear Medicine imaging in heart amyloidosis. Imaging in University Clinical Center of Serbia
9:45-10:00 Discussion

2

Experience of nuclear medicine centres in Serbia in imaging cardiac amyloidosis

Chairpersons: Dragana Sobic Saranovic, Milos Stevic

10:15-10:30 Veljko Crnobrnja, KCV TRANSTHYRETIN AMYLOIDOSIS: Multimodality Approach for Definitive Diagnosis
10:30-10:45 Milos Stevic, UKC Nis Diagnosis of transthyretin amylodisis-recent experiences and case reports
10:45-11:00 Marija Sisic, VMA Experiences from Institute for Nuclear Medicine MMA in diagnosis of heart amyloidosis.
11:00-11:15 Vesna Ignjatovic, UKC Kragujevac Nuclear medicine imaging for the diagnosis of cardiac amyloidosis – single center experience
11:15-11:25 Discussion
11:30-12:00 Commercial Symposium Pfizer Chairperson: Arsen Ristic
Danijela Trifunovic Zamaklar:The significance of echocardiography in the diagnostic puzzle of amyloidosis
Dragana Sobic Saranovic: Nuclear Medicine imaging in heart amyloidosis
12:00-13:00 Welcome buffet

3

 Theranostics in prostate carcinoma
Chairpersons: Slobodanka Beatović, Vladimir Vukomanović
13:00-13:20 Marcus Hacker, Vienna Total body PET/CT in diagnosis of prostate carcinomas
13:20-13:40 Sabina Dizdarević, Brighton Diagnosis and treatment of prostate carcinomas with radionuclide methods
13:40-13:55 Vihren Marinov, Sofia Hands-on experience with Lutetium Therapy
13:55-14:10 Marko Grahovac, Vienna AI in nuclear medicine theranostics
14:10-14:20 Discussion
14:20-14:35 Commercial Symposium Novartis
14:35-14:50 Commercial Symposium Merck: 50 godina leka Euthyrox u lečenju pacijenata sa hipotireozom.  Miloš Žarković: Individualni pristup terapije kod pacijenata sa hipotireozom- značaj fine titracije lekom Euthyrox

 

4

 Theragnostics in Thyroid Disease
Chairpersons: Branislava Ilinčić, Jasna Mihailović, Aleksandar Simić
14:50-15:05 Miloš Žarković, Beograd Artificial intelligence use in the diagnostic of thyroid nodules
15:05-15:20 Jasna Mihailović, Novi Sad Differentiated thyroid carcinomas, diagnosis and therapy
15:20-15:35 Raluca Mititelu, Bucharest FDG PET-CT in thyroid cancer
15:35-15:50 Tamara Anđelković Refractory thyroid carcinoma
15:50-16:00

Discussion
16:00-16:10

Coffee break

5

 Theragnostics in NET

Chairpersons: Vera Artiko, Sanja Vranješ Djurić
16:10-16:30 Clemens Decristoforo, Insbruck New challenges in theranostic radiopharmacy
16:30-16:45 Djuro Macut, Belgrade Medullary thyroid carcinoma-diagnostic and therapeutic possibilities
16:45-17:00 Branislava Radović, Belgrade Radionuclide teranostics of medullary thyroid carcinomas
17:00-17:15 Discussion

Friday, November 8, 2024

6

The Achievements in Nuclear Medicine 2023: “Milovan Antić” competition

Chairpersons: Marija Šišić, Slobodanka Beatović, Drina Janković
9:30-9:45 Introduction
9:45-10:00 Marija Jeremić Radioactivity of biological samples of patients treated with 90Y-DOTATOC
10:00-10:15 Ana Koljević Marković Evaluation of Vitamin D3 levels and dietary management in patients with papillary thyroid cancer. Hell J Nucl Med 2023; 26(3): 186-198
10:20-10:30 Ospita specijalna bolnica
Dr Aida Afgan		 PET-CT dijagnostika
Award “Vladimir Bošnjaković” for 2024
10:30-11:00 Chairpersons: Leposava Brajković, Vera Artiko
11:15-12:00 Assembly, Serbian Society of Nuclear Medicine
12:00-12:30 Light refreshment